Marksans pharma acquires Relonchem of UK

Subscribe to Oneindia News

Mumbai, Aug 28 (UNI) Leading mid-sized Pharma Company Marksans Pharmaceutical Limited today announced the acquisition of Relonchem Limited, a leading UK based generic pharmaceutical company, for an undisclosed sum.

Relonchem Limited has clocked sales of about USD 32 million and adjusted EBITDA of USD 5 million in the FY 2007. The acquisition will give Marksans Pharma an immediate sales and marketing front-end access to the highly regulated and lucrative generic medicines market in UK and Europe, the company said in a release here. It expected to derive significant cost benefits by transferring Relonchem Limited's manufacturing operations to its state-of-the-art India manufacturing facilities.

The release said at a macro level, this is another important step by the Company in creating a complete value chain of self-sufficient business models for itself. While building state-of-the-art, regulatory compliant manufacturing and R&D facilities in India that enjoy cost efficiencies, the Company is also creating front-end marketing and distributor network for sales across the world. Thus, reduced costs and a self-owned network of front-end distribution, marketing and sales capabilities will lead to higher margins and profits, while adding significant value to the healthcare systems across the globe.

UNI VK SR

Please Wait while comments are loading...